Esperion Therapeutics Inc (NASDAQ:ESPR)

83.16
Delayed Data
As of Jul 02
 +0.89 / +1.08%
Today’s Change
13.90
Today|||52-Week Range
120.96
+105.64%
Year-to-Date

Today’s Trading

Previous close82.27
Today’s open82.67
Day’s range80.81 - 83.77
Volume356,828
Average volume (3 months)820,322
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+32.93%
Earnings growth (this year)-10.22%
Earnings growth (next 5 years)-21.89%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book12.45

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp-0.11-0.21%
AXONAxovant Sciences Ltd-0.44-2.23%
MCRBSeres Therapeutics I...+0.31+0.78%
MNTAMomenta Pharmaceutic...-1.16-5.17%
Data as of 4:01pm ET, 07/02/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers